D. S. Dede Et Al. , "Evaluation of changes of biologic markers ER, PR, HER 2 and Ki-67 in breast cancer with administration of neoadjuvant dose-dense doxorubicin, cyclophosphamide followed by paclitaxel," JOURNAL OF BUON , vol.18, no.1, pp.57-63, 2013
Dede, D. S. Et Al. 2013. Evaluation of changes of biologic markers ER, PR, HER 2 and Ki-67 in breast cancer with administration of neoadjuvant dose-dense doxorubicin, cyclophosphamide followed by paclitaxel. JOURNAL OF BUON , vol.18, no.1 , 57-63.
Dede, D. S., Gumuskaya, B., Guler, G., Onat, D., Altundag, K., & Ozisik, Y., (2013). Evaluation of changes of biologic markers ER, PR, HER 2 and Ki-67 in breast cancer with administration of neoadjuvant dose-dense doxorubicin, cyclophosphamide followed by paclitaxel. JOURNAL OF BUON , vol.18, no.1, 57-63.
Dede, D. Et Al. "Evaluation of changes of biologic markers ER, PR, HER 2 and Ki-67 in breast cancer with administration of neoadjuvant dose-dense doxorubicin, cyclophosphamide followed by paclitaxel," JOURNAL OF BUON , vol.18, no.1, 57-63, 2013
Dede, D. S. Et Al. "Evaluation of changes of biologic markers ER, PR, HER 2 and Ki-67 in breast cancer with administration of neoadjuvant dose-dense doxorubicin, cyclophosphamide followed by paclitaxel." JOURNAL OF BUON , vol.18, no.1, pp.57-63, 2013
Dede, D. S. Et Al. (2013) . "Evaluation of changes of biologic markers ER, PR, HER 2 and Ki-67 in breast cancer with administration of neoadjuvant dose-dense doxorubicin, cyclophosphamide followed by paclitaxel." JOURNAL OF BUON , vol.18, no.1, pp.57-63.
@article{article, author={D. S. Dede Et Al. }, title={Evaluation of changes of biologic markers ER, PR, HER 2 and Ki-67 in breast cancer with administration of neoadjuvant dose-dense doxorubicin, cyclophosphamide followed by paclitaxel}, journal={JOURNAL OF BUON}, year=2013, pages={57-63} }